Stay updated on A4250 in Children With PFIC Clinical Trial
Sign up to get notified when there's something new on the A4250 in Children With PFIC Clinical Trial page.

Latest updates to the A4250 in Children With PFIC Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoNo Change Detected
- Check15 days agoChange Detected- A 403 Forbidden page is added/updated, including a basic HTML header, the message '403 Forbidden', a Home link, and a revision label (Revision: v3.7.0), reflecting the access-restricted state of the page.SummaryDifference19%

- Check29 days agoChange DetectedOpen-label extension study details for A4250 in PFIC were added, outlining long-term safety, dosing, and multiple outcomes across many sites; the previous extension description was removed.SummaryDifference3%

- Check36 days agoChange DetectedThe page now shows an NIH grant/contract funding note for 2017, and the site revision tag was updated to v3.6.6 (from v3.6.5).SummaryDifference0.1%

- Check57 days agoChange DetectedThe page's revision label updates from v3.6.4 to v3.6.5, signaling a small maintenance/update to the page. No study content or data is affected by this change.SummaryDifference0.0%

- Check72 days agoChange DetectedThe page now shows Revision: v3.6.4, replacing the previous Revision: v3.6.3. This indicates a small document revision without changes to the main study information.SummaryDifference0.0%

- Check93 days agoChange DetectedThe page now shows Revision: v3.6.3 instead of v3.6.2. This indicates a small update to the site's documentation assets.SummaryDifference0.0%

Stay in the know with updates to A4250 in Children With PFIC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the A4250 in Children With PFIC Clinical Trial page.